Showing results (171-180 of 461) with videos related to
Sort By:
Pageof 47
British Journal of Haematology|July 21, 2005
Der(6)t(1;6)(q21-23;p21.3): a specific cytogenetic abnormality in myelofibrosis with myeloid metaplasiaDavid Dingli, Francis H Grand, Victor Mahaffey, et al.Mayo Clinic Proceedings|January 7, 2018
Safety Outcomes for Autologous Stem Cell Transplant in Multiple MyelomaMorie A Gertz, Francis K Buadi, Suzanne R Hayman, et al.Cancer Medicine|December 21, 2025
Healthcare Resource Utilization and Costs in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia Treated With Covalent Bruton's Tyrosine Kinase Inhibitors: Real-World Impact of Cardiovascular Adverse EventsMavis Obeng-Kusi, Enrico De Nigris, Siyang Leng, et al.Transplantation and Cellular Therapy|June 21, 2021
The Efficacy and Safety of Chemotherapy-Based Stem Cell Mobilization in Multiple Myeloma Patients Who Are Poor Responders to Induction: The Mayo Clinic ExperienceIuliana Vaxman, Eli Muchtar, Eapen Jacob, et al.Leukemia & Lymphoma|May 13, 2022
Lack of a caregiver is associated with shorter survival in myeloma patients undergoing autologous stem cell transplantationMorie A Gertz, Rahma Warsame, Eli Muchtar, et al.Cancer Research|August 2, 2014
Dynamics of leukemia stem-like cell extinction in acute promyelocytic leukemiaBenjamin Werner, Robert E Gallagher, Elisabeth M Paietta, et al.Cancer|October 20, 2011
Early versus delayed autologous transplantation after immunomodulatory agents-based induction therapy in patients with newly diagnosed multiple myelomaShaji K Kumar, Martha Q Lacy, Angela Dispenzieri, et al.Leukemia & Lymphoma|July 9, 2016
Impact of pre-transplant bone marrow plasma cell percentage on post-transplant response and survival in newly diagnosed multiple myelomaRajshekhar Chakraborty, Eli Muchtar, Shaji K Kumar, et al.Blood|June 18, 2005
Circulating plasma cells detected by flow cytometry as a predictor of survival in 302 patients with newly diagnosed multiple myelomaGrzegorz S Nowakowski, Thomas E Witzig, David Dingli, et al.American Journal of Hematology|November 10, 2009
Idiotype-pulsed antigen-presenting cells following autologous transplantation for multiple myeloma may be associated with prolonged survivalMartha Q Lacy, Sumithra Mandrekar, Angela Dispenzieri, et al.Pageof 47